全文获取类型
收费全文 | 8559篇 |
免费 | 587篇 |
国内免费 | 132篇 |
专业分类
耳鼻咽喉 | 64篇 |
儿科学 | 221篇 |
妇产科学 | 396篇 |
基础医学 | 963篇 |
口腔科学 | 194篇 |
临床医学 | 1055篇 |
内科学 | 1741篇 |
皮肤病学 | 78篇 |
神经病学 | 715篇 |
特种医学 | 321篇 |
外科学 | 1096篇 |
综合类 | 242篇 |
一般理论 | 4篇 |
预防医学 | 477篇 |
眼科学 | 181篇 |
药学 | 716篇 |
中国医学 | 84篇 |
肿瘤学 | 730篇 |
出版年
2023年 | 44篇 |
2022年 | 104篇 |
2021年 | 179篇 |
2020年 | 105篇 |
2019年 | 177篇 |
2018年 | 210篇 |
2017年 | 179篇 |
2016年 | 176篇 |
2015年 | 248篇 |
2014年 | 287篇 |
2013年 | 385篇 |
2012年 | 548篇 |
2011年 | 618篇 |
2010年 | 416篇 |
2009年 | 352篇 |
2008年 | 504篇 |
2007年 | 526篇 |
2006年 | 522篇 |
2005年 | 465篇 |
2004年 | 399篇 |
2003年 | 331篇 |
2002年 | 294篇 |
2001年 | 271篇 |
2000年 | 229篇 |
1999年 | 197篇 |
1998年 | 86篇 |
1997年 | 93篇 |
1996年 | 86篇 |
1995年 | 56篇 |
1994年 | 46篇 |
1993年 | 46篇 |
1992年 | 113篇 |
1991年 | 119篇 |
1990年 | 96篇 |
1989年 | 80篇 |
1988年 | 77篇 |
1987年 | 79篇 |
1986年 | 53篇 |
1985年 | 44篇 |
1984年 | 38篇 |
1983年 | 38篇 |
1982年 | 21篇 |
1981年 | 31篇 |
1980年 | 23篇 |
1979年 | 28篇 |
1978年 | 33篇 |
1977年 | 19篇 |
1976年 | 24篇 |
1975年 | 20篇 |
1974年 | 26篇 |
排序方式: 共有9278条查询结果,搜索用时 15 毫秒
991.
The Ku antigen is a heterodimer consisting of 70- and 80-kD protein subunits that binds to termini of double-stranded DNA. DNA binding appears to be mediated partly by the 70-kD (p70) subunit, but the precise mechanism of its association with DNA is unclear. High-titer autoantibodies in sera from certain patients with systemic lupus erythematosus recognize at least eight distinct epitopes of Ku, and inhibit DNA binding. In the present studies, the binding of DNA to truncated p70 fusion proteins was determined in Southwestern blots and DNA immunoprecipitation assays. Appropriate folding of the p70 protein was crucial for efficient DNA binding. The minimal DNA binding site, amino acids 536-609, contains a major conformational autoepitope of p70 (amino acids 560-609). Deletion of amino acids 601-609, or substitution of ala-ala-ala for lys-ser-gly at positions 591-593, eliminated DNA binding as well as autoantibody binding, suggesting that the same secondary or supersecondary structure is involved in both DNA binding and autoantibody recognition. Residues within the DNA binding site/autoepitope closely resemble the helix-turn-helix motif in bacteriophage lambda Cro protein and certain other DNA binding proteins, and mutations predicted to destabilize this structure eliminated DNA binding. Adjacent to the helix-turn-helix is a highly basic domain (positions 539-559) that was also required for DNA binding. The findings suggest that the DNA binding site of p70 consists of a basic domain adjacent to a helix-turn-helix structure that also forms a major autoepitope. 相似文献
992.
Impaired neutrophil activity and increased susceptibility to bacterial infection in mice lacking glucose-6-phosphatase-beta 下载免费PDF全文
Cheung YY Kim SY Yiu WH Pan CJ Jun HS Ruef RA Lee EJ Westphal H Mansfield BC Chou JY 《The Journal of clinical investigation》2007,117(3):784-793
Neutropenia and neutrophil dysfunction are common in many diseases, although their etiology is often unclear. Previous views held that there was a single ER enzyme, glucose-6-phosphatase-alpha (G6Pase-alpha), whose activity--limited to the liver, kidney, and intestine--was solely responsible for the final stages of gluconeogenesis and glycogenolysis, in which glucose-6-phosphate (G6P) is hydrolyzed to glucose for release to the blood. Recently, we characterized a second G6Pase activity, that of G6Pase-beta (also known as G6PC), which is also capable of hydrolyzing G6P to glucose but is ubiquitously expressed and not implicated in interprandial blood glucose homeostasis. We now report that the absence of G6Pase-beta led to neutropenia; defects in neutrophil respiratory burst, chemotaxis, and calcium flux; and increased susceptibility to bacterial infection. Consistent with this, G6Pase-beta-deficient (G6pc3-/-) mice with experimental peritonitis exhibited increased expression of the glucose-regulated proteins upregulated during ER stress in their neutrophils and bone marrow, and the G6pc3-/- neutrophils exhibited an enhanced rate of apoptosis. Our results define a molecular pathway to neutropenia and neutrophil dysfunction of previously unknown etiology, providing a potential model for the treatment of these conditions. 相似文献
993.
This study proposes a cost-effective, energy-saving, and green process that uses π–π interactions to modify graphene oxide (GO), and the conjugate structure of aniline tetramer (AT) to enhance the dispersion of GO. Au/aniline tetramer–graphene oxide (Au/ATGO) composites were synthesized and applied as a catalyst in this study. The adsorption of AT on GO, via π–π interaction, formed ATGO composites. Subsequently, the amine group on ATGO was stably anchored on Au nanoparticles (Au NPs) to form Au/ATGO composites. The Au/ATGO composites were characterized and the electroactive properties determined by Fourier-transform infrared spectroscopy, X-ray photoelectron spectroscopy, transmission electron microscopy, and cyclic voltammetry. The Au/ATGO composites showed excellent performance and stability as catalysts when applied for the reduction of nitrophenol to aminophenol within 225 s and the rate constant was 0.02 s−1. The activation energy for the reduction of 4-NP and 2-NP was 48.10 and 68.71 kJ mol−1, respectively. Following a recycling test repeated 20 times, the Au/ATGO composites maintained a conversion rate higher than 94%.The stable and reusable Au/ATGO composites were prepared. Aniline tetramer not only modified GO but also can anchor Au NPs. The Au/ATGO composites as a catalyst exhibit good cycling stability. 相似文献
994.
Effect of metabolic clearance rate and hepatic extraction of insulin on hepatic and peripheral contributions to hypoglycemia. 下载免费PDF全文
Z Chap T Ishida J Chou C J Hartley R M Lewis M Entman J B Field 《The Journal of clinical investigation》1985,76(6):2222-2234
Effects of alterations in metabolic clearance rates, hepatic extraction, and plasma concentrations of insulin on hepatic and peripheral contribution to hypoglycemia and glucose counterregulation were studied in conscious dogs. Since insulin and sulfated insulin had markedly different metabolic clearance rates (34 +/- 1 vs. 16 +/- 1 ml/kg per min, respectively) and fractional hepatic extraction (42 +/- 1% vs. 15 +/- 2%, respectively), biologically equivalent amounts infused intraportally produced twofold higher hepatic vein and artery sulphated insulin concentrations and concentrations that were 30% higher in the portal vein. This significantly larger arterial/portal concentration ratio (0.67 vs. 0.45, respectively) permitted assessment of differential distribution of insulin on glucose turnover using [3-3H]glucose. Insulin and sulfated insulin (1 and 2 mU/kg per min) caused similar hypoglycemia. While insulin transiently suppressed glucose production and increased glucose disappearance, sulfated insulin had significantly greater effects on glucose disappearance and clearance, without suppression of glucose production. Despite similar hypoglycemia, sulfated insulin caused greater increment in glucagon. 3 mU/kg per min insulin caused more rapid and greater hypoglycemia, greater glucose clearance, and greater glucagon increments without suppression of glucose production, which indicates that with larger doses of insulin counterregulation can absolutely mask the suppressive effect of insulin. The effects of insulin and sulfated insulin were evaluated using euglycemic clamp to eliminate interference from stimulated counterregulation. Sequential infusion of 1 and 2 mU/kg per min of both insulins suppressed endogenous glucose production to 0 at 150 min, which indicates that the apparent lack of a hepatic effect of sulfated insulin during hypoglycemia was masked by greater counterregulation. This greater counterregulation may reflect greater peripheral glucose clearance, and prevented greater hypoglycemia than after the same insulin doses. The results indicate that the different rates of removal and the total metabolic clearance rate caused different concentrations and relative distribution between the portal and arterial blood compartments, leading to the significantly different contributions by the liver and peripheral tissues to the same hypoglycemia. 相似文献
995.
Selective Serotonin Reuptake Inhibitors and Poststroke Epilepsy: A Population-Based Nationwide Study
Chien-Chen Chou Der-Jen Yen Yung-Yang Lin Yu-Chiao Wang Cheng-Li Lin Chia-Hung Kao 《Mayo Clinic proceedings. Mayo Clinic》2017,92(2):193-199
Objective
To investigate the effects of selective serotonin reuptake inhibitors (SSRIs) on poststroke epilepsy in a population-based nationwide study.Patients and Methods
The SSRI group included patients who received a stroke diagnosis from January 1, 2000, through December 31, 2009, and were prescribed SSRIs after stroke. The non-SSRI group enrolled patients with stroke who were not prescribed SSRIs from the Taiwan National Health Insurance Research Database and used propensity score matching based on the index year, duration time, sex, age, type of stroke, and duration of hospitalization. Cox proportional hazards models were used to estimate the risk of epilepsy between the SSRI and comparison groups.Results
A total of 4688 patients with stroke (2344 in each of the SSRI and non-SSRI cohorts) were enrolled. The cumulative incidence of epilepsy in the SSRI group was significantly higher than that in the comparison group (log-rank P<.001). In the SSRI group, the risk of poststroke epilepsy increased 2.45-fold (95% CI, 1.69- to 3.57-fold) compared with that in the comparison group. Furthermore, the risk of poststroke epilepsy increased with the defined daily dose of SSRIs. For patients with ischemic stroke, SSRIs users had a 2.74-fold higher risk of epilepsy than non users (95% CI, 1.79- to 4.22-fold).Conclusion
In this study, SSRI users had a higher risk of poststroke epilepsy than nonusers. Further study is warranted to investigate the causal relationship between SSRI exposure and poststroke epilepsy. 相似文献996.
Identification of mutations in the gene for glucose-6-phosphatase, the enzyme deficient in glycogen storage disease type 1a. 总被引:5,自引:1,他引:5 下载免费PDF全文
K J Lei C J Pan L L Shelly J L Liu J Y Chou 《The Journal of clinical investigation》1994,93(5):1994-1999
Glycogen storage disease (GSD) type 1a is an autosomal recessive inborn error of metabolism caused by a deficiency in microsomal glucose-6-phosphatase (G6Pase), the key enzyme in glucose homeostasis. Southern blot hybridization analysis using a panel of human-hamster hybrids showed that human G6Pase is a single-copy gene located on chromosome 17. To correlate specific defects with clinical manifestations of this disorder, we identified mutations in the G6Pase gene of GSD type 1a patients. In the G6Pase gene of a compound heterozygous patient (LLP), two mutations in exon 2 of one allele and exon 5 of the other allele were identified. The exon 2 mutation converts an arginine at codon 83 to a cysteine (R83C). This mutation, previously identified by us in another GSD type 1a patient, was shown to have no detectable phosphohydrolase activity. The exon 5 mutation in the G6Pase gene of LLP converts a glutamine codon at 347 to a stop (Q347SP). This Q347SP mutation was also detected in all exon 5 subclones (five for each patient) of two homozygous patients, KB and CB, siblings of the same parents. The predicted Q347SP mutant G6Pase is a truncated protein of 346 amino acids, 11 amino acids shorter than the wild type G6Pase of 357 residues. Site-directed mutagenesis and transient expression assays demonstrated that G6Pase-Q347SP was devoid of G6Pase activity. G6Pase is an endoplasmic reticulum (ER) membrane-associated protein containing an ER retention signal, two lysines (KK), located at residues 354 and 355. We showed that the G6Pase-K355SP mutant containing a lysine-355 to stop codon mutation is enzymatically active. Our data demonstrate that the ER protein retention signal in human G6Pase is not essential for activity. However, residues 347-354 may be required for optimal G6Pase catalysis. 相似文献
997.
Nian-Sheng Tzeng Chi-Hsiang Chung Feng-Cheng Liu Yu-Hsiang Chiu Hsin-An Chang Chin-Bin Yeh San-Yuan Huang Ru-Band Lu Hui-Wen Yeh Yu-Chen Kao Wei-Shan Chiang Chang-Hui Tsao Yung-Fu Wu Yu-Ching Chou Fu-Huang Lin Wu-Chien Chien 《The American journal of the medical sciences》2018,355(2):153-161
Background
Fibromyalgia is a syndrome of chronic pain and other symptoms and is associated with patient discomfort and other diseases. This nationwide matched-cohort population-based study aimed to investigate the association between fibromyalgia and the risk of developing dementia, and to clarify the association between fibromyalgia and dementia.Materials and Methods
A total of 41,612 patients of age ≥50 years with newly diagnosed fibromyalgia between January 1, and December 31, 2000 were selected from the National Health Insurance Research Database of Taiwan, along with 124,836 controls matched for sex and age. After adjusting for any confounding factors, Fine and Gray competing risk analysis was used to compare the risk of developing dementia during the 10 years of follow-up.Results
Of the study subjects, 1,704 from 41,612 fibromyalgia patients (21.23 per 1,000 person-years) developed dementia when compared to 4,419 from 124,836 controls (18.94 per 1,000 person-years). Fine and Gray competing risk analysis revealed that the study subjects were more likely to develop dementia (hazard ratio: 2.29, 95% CI: 2.16-2.42; P < 0.001). After adjusting for sex, age, monthly income, urbanization level, geographic region of residence and comorbidities the hazard ratio was 2.77 (95% CI: 2.61-2.95, P < 0.001). Fibromyalgia was associated with increased risk of all types of dementia in this study.Conclusions
The study subjects with fibromyalgia had a 2.77-fold risk of dementia in comparison to the control group. Therefore, further studies are needed to elucidate the underlying mechanisms of the association between fibromyalgia and the risk of dementia. 相似文献998.
Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation for Multiple Myeloma: Results from the Japan Myeloma Study Group 总被引:2,自引:0,他引:2
Shimazaki C Fujii H Yoshida T Chou T Nishimura M Asaoku H Miyawaki S Ishii A Ishida T Taniwaki M Iida S Takagi T Takatsuki K;Japan Myeloma Study Group 《International journal of hematology》2005,81(4):342-348
We conducted a retrospective survey of multiple myeloma (MM) patients who underwent reduced-intensity conditioning allogeneic stem cell transplantation (RIST) at 11 hospitals participating in the Japan Myeloma Study Group. Forty-five patients (median age, 53 years) were included in this study. The conditioning regimen consisted of a fludarabine-based regimen in 24 patients and a regimen based on total body irradiation (1-2 Gy) in 18 patients. Graft-versus-host disease (GVHD) prophylaxis consisted of cyclosporine and tacrolimus in 28 and 17 patients, respectively. All patients showed myeloid engraftment. Complete chimerism was obtained in 42 patients. Grade II to IV acute GVHD developed in 28 (65%) of 43 patients evaluated, and chronic GVHD developed in 31 (76%) of 41 patients. Early death before day 100 was observed in 4 patients (8.8%). A complete response (CR) was obtained in 12 patients. The factors affecting overall survival were severe acute GVHD and the response after RIST. To date, 18 patients are alive, with 9 patients remaining in CR at a median follow-up of 25 months. The overall and progression-free survival rates at 3 years were 38.5% and 18.8%, respectively. These observations suggest that RIST is feasible with reliable donor engraftment and relatively low transplantation-related mortality in Japanese MM patients. 相似文献
999.
Dunn W Chou C Li H Hai R Patterson D Stolc V Zhu H Liu F 《Proceedings of the National Academy of Sciences of the United States of America》2003,100(24):14223-14228
Human cytomegalovirus (HCMV), a ubiquitous herpesvirus, causes a lifelong subclinical infection in healthy adults but leads to significant morbidity and mortality in neonates and immunocompromised individuals. Its ability to grow in different cell types is responsible for HCMV-associated diseases, including mental retardation and retinitis, and vascular disorders. To globally assess viral gene function for replication in cells, we determined the genomic sequence of a bacterial artificial chromosome (BAC)-based clone of HCMV Towne strain and used this information to delete each of its 162 unique ORFs and generate a collection of viral mutants. The growth of these mutants in different cultured cells was examined to systematically investigate the necessity of each ORF for replication. Our results showed that 45 ORFs are essential for viral replication in fibroblasts and 117 are nonessential. Some genes were found to be required for viral replication in retinal pigment epithelial cells and microvascular endothelial cells, but not in fibroblasts, indicating their role as tropism factors. Interestingly, several viral mutants grew 10- to 500-fold better than the parental strain in different cell types, suggesting that the deleted ORFs encode replication temperance or repressing functions. Thus, HCMV encodes supportive and suppressive growth regulators for optimizing its replication in human fibroblasts, epithelial, and endothelial cells. Suppression of viral replication by virus-encoded temperance factors represents a novel mechanism for regulating the growth of an animal virus, and may contribute to HCMV's optimal infection of different tissues and successful proliferation among the human population. 相似文献
1000.
Phase II trial of 2-chlorodeoxyadenosine for the treatment of cutaneous T-cell lymphoma [see comments] 总被引:1,自引:0,他引:1
Kuzel TM; Hurria A; Samuelson E; Tallman MS; Roenigk HH Jr; Rademaker AW; Rosen ST 《Blood》1996,87(3):906-911
We investigated the efficacy of 2-chlorodeoxyadenosine (2-CdA) therapy in patients with mycosis fungoides (MF) and the Sezary syndrome (SS). Between February 1991 and November 1993, 21 patients with relapsed or refractory MF/SS were treated with 2-CdA. 2-CdA was administered by continuous intravenous infusion at a dose of 0.1 mg/kg/d for 7 days initially (13 patients), but was subsequently reduced to 5 days (nine patients) due to hematologic toxicity. All patients had failed to respond to at least one prior treatment for MF/SS (median number of total prior therapies, five; median number of systemic prior therapies, three) and had an Eastern Cooperative Oncology Group performance status of two or better. Cycles were administered at 28-day intervals. Assessable patients received at least 5 days of 2-CdA. Fourteen patients received more than one cycle of 2-CdA. An overall response rate of 28% was achieved. Three patients (14%) had a complete response with a median duration of 4.5 months (range, 2.5 to 16). Three (14%) had a partial response with a median duration of 2 months (range, 2 to 4). Fifteen patients (72%) had no response. The most significant toxicities encountered were bone marrow suppression (62% of patients) and infectious complications (62% of patients). Thirty-eight percent of patients experienced no toxicity from 2-CdA. 2-CdA has activity as a single agent in patients with previously treated relapsed MF/SS. Studies in less heavily pretreated individuals with 2-CdA alone or in combination will be undertaken. 相似文献